PEAK6 Investments’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-16,600
Closed -$301K 6070
2021
Q3
$301K Sell
16,600
-11,900
-42% -$273K ﹤0.01% 3666
2021
Q2
$770K Buy
28,500
+28,400
+28,400% +$795K ﹤0.01% 2838
2021
Q1
$3K Sell
100
-20,800
-100% -$709K ﹤0.01% 4730
2020
Q4
$601K Sell
20,900
-10,200
-33% -$275K ﹤0.01% 2935
2020
Q3
$759K Buy
31,100
+25,600
+465% +$552K ﹤0.01% 2512
2020
Q2
$98K Buy
+5,500
New +$72.3K ﹤0.01% 3807

Other funds holding CVET

PEAK6 Investments's CVET Position: Q4 2021 in Review

PEAK6 Investments sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2021, closing a stake of 12,227 shares — an estimated $222K sold.

PEAK6 Investments first reported a position in CVET in Q2 2021 and held it in 2 quarters. The position peaked at $222K in Q3 2021. 246 funds tracked by Wall St. Rank hold CVET as of Q4 2021.

  • PEAK6 Investments reported no remaining Covetrus, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • PEAK6 Investments sold 12,227 Covetrus, Inc. Common Stock shares in Q4 2021, an estimated $222K.
  • PEAK6 Investments first reported a position in Covetrus, Inc. Common Stock in Q2 2021 and held it in 2 quarters.
  • PEAK6 Investments's Covetrus, Inc. Common Stock position peaked at $222K in Q3 2021.
  • 246 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2021.

Based on PEAK6 Investments's 13F filing for Q4 2021, filed 11 Feb 2022.